| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ad53b64eb74859acdc01278829b080 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-203332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-173845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-200833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2014-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0195c53a4fc12f4622a87d7d74e6b77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a297e263f54d978e7f94f0a519bf48fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6960de860a349594fbec9505daae9ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3308c63fba015c5b3500021ae26e7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55a8f647cea1cdb8030c3da372a94598 |
| publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015072363-A1 |
| titleOfInvention |
Phenylacetylglutamine as a biomarker for healthy aging |
| abstract |
Using NMR/MS based metabonomics and targeted lipidomics approaches the inventors have explored the metabolic phenotypes of aging and longevity in a cohort compromising centenarians, elderly and young adults. The inventors have identified biomarkers for a reduced risk of developing ageing related chronic inflammatory disorders and propose an in vitro method of diagnosing a lifestyle that allows delaying and/or avoiding ageing related chronic inflammatory disorders using phenylacetylglutamine (PAG) as biomarker. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9817003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11244752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105486799-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9341615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9322821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105717205-A |
| priorityDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |